Download PDF
Semin intervent Radiol 2018; 35(01): 009-016
DOI: 10.1055/s-0038-1636515
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Gender Differences in Peripheral Vascular Disease

Kristofer Schramm
1   Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado
,
Paul J. Rochon
1   Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
05 April 2018 (online)

Also available at
    Permissions and Reprints

Abstract

In the past 20 years, peripheral artery disease (PAD) has been increasingly recognized as a significant cause of morbidity and mortality in the United States. PAD has traditionally been identified as a male-dominant disease; however, recent population trends and studies in PAD suggest that women are affected at least as often as men. Women comprise a larger population of the elderly than men, as well as an increasing proportion of patients with PAD. Much of the existing research on PAD has focused on whole populations, and gender-specific data on PAD is sparse. This review focuses on gender-specific differences in presentation, management, and outcomes of PAD intervention that are important considerations for the interventional radiologist.

Keywords

interventional radiology - peripheral arterial disease - gender - medical therapy
 

  • References

  • 1 Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. Natl Vital Stat Rep 2016; 65 (04) 1-122
    PubMedGoogle Scholar
  • 2 Taylor SM. Commentary. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Perspect Vasc Surg Endovasc Ther 2008; 20 (03) 314-316
    CrossrefPubMedGoogle Scholar
  • 3 Wenger NK. Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation 2012; 126 (05) 604-611
    CrossrefPubMedGoogle Scholar
  • 4 Mahoney EM, Wang K, Cohen DJ. , et al; REACH Registry Investigators. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes 2008; 1 (01) 38-45
    CrossrefPubMedGoogle Scholar
  • 5 Walker JP, Hiramoto JS. Diagnosis and management of peripheral artery disease in women. Int J Womens Health 2012; 4: 625-634
    PubMedGoogle Scholar
  • 6 Hoel AW, Kayssi A, Brahmanandam S, Belkin M, Conte MS, Nguyen LL. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J Vasc Surg 2009; 50 (02) 349-354
    CrossrefPubMedGoogle Scholar
  • 7 Mendis S, Puska P, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization; 2011
    Google Scholar
  • 8 Kuller LH, Matthews KA, Edmundowicz D, Chang Y. Incident coronary artery calcium among postmenopausal women. Atherosclerosis 2008; 200 (02) 278-285
    CrossrefPubMedGoogle Scholar
  • 9 Daviglus ML, Stamler J, Pirzada A. , et al. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA 2004; 292 (13) 1588-1592
    CrossrefPubMedGoogle Scholar
  • 10 Willigendael EM, Teijink JA, Bartelink M-L. , et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004; 40 (06) 1158-1165
    CrossrefPubMedGoogle Scholar
  • 11 Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J 1999; 20 (05) 344-353
    CrossrefPubMedGoogle Scholar
  • 12 Jamal A, Homa DM, O'Connor E. , et al. Current cigarette smoking among adults - United States, 2005-2014. MMWR Morb Mortal Wkly Rep 2015; 64 (44) 1233-1240
    PubMedGoogle Scholar
  • 13 Westendorp IC, in't Veld BA, Grobbee DE. , et al. Hormone replacement therapy and peripheral arterial disease: the Rotterdam study. Arch Intern Med 2000; 160 (16) 2498-2502
    CrossrefPubMedGoogle Scholar
  • 14 Rossouw JE, Anderson GL, Prentice RL. , et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288 (03) 321-333
    CrossrefPubMedGoogle Scholar
  • 15 Grady D, Herrington D, Bittner V. , et al; HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288 (01) 49-57
    CrossrefPubMedGoogle Scholar
  • 16 Hsia J, Criqui MH, Herrington DM. , et al; Women's Health Initiative Research Group. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J 2006; 152 (01) 170-176
    CrossrefPubMedGoogle Scholar
  • 17 Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987; 3 (02) 463-524
    CrossrefPubMedGoogle Scholar
  • 18 Brun E, Nelson RG, Bennett PH. , et al; Verona Diabetes Study. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000; 23 (08) 1119-1123
    CrossrefPubMedGoogle Scholar
  • 19 Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985; 33 (01) 13-18
    CrossrefPubMedGoogle Scholar
  • 20 Smith Jr SC, Haslam D. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk--the Shape of the Nations survey. Curr Med Res Opin 2007; 23 (01) 29-47
    CrossrefPubMedGoogle Scholar
  • 21 Cabrera MA, Gebara OC, Diament J, Nussbacher A, Rosano G, Wajngarten M. Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women. Int J Cardiol 2007; 114 (02) 224-229
    CrossrefPubMedGoogle Scholar
  • 22 Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96 (09) 939-949
    CrossrefPubMedGoogle Scholar
  • 23 Giusti V. Management of obesity in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2007; 34 (05) 576-582
    CrossrefPubMedGoogle Scholar
  • 24 Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969; 56 (09) 676-679
    CrossrefPubMedGoogle Scholar
  • 25 Rooke TW, Hirsch AT, Misra S. , et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline. J Vasc Surg 2011; 54 (05) e32-e58
    CrossrefPubMedGoogle Scholar
  • 26 Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res 2015; 116 (09) 1509-1526
    CrossrefPubMedGoogle Scholar
  • 27 Allison MA, Ho E, Denenberg JO. , et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med 2007; 32 (04) 328-333
    CrossrefPubMedGoogle Scholar
  • 28 Hirsch AT, Allison MA, Gomes AS. , et al. A call to action: women and peripheral artery disease. Circulation 2012; 125 (11) 1449-1472
    CrossrefPubMedGoogle Scholar
  • 29 Diehm C, Schuster A, Allenberg JR. , et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172 (01) 95-105
    CrossrefPubMedGoogle Scholar
  • 30 Hirsch AT, Criqui MH, Treat-Jacobson D. , et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286 (11) 1317-1324
    CrossrefPubMedGoogle Scholar
  • 31 Sigvant B, Wiberg-Hedman K, Bergqvist D. , et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007; 45 (06) 1185-1191
    CrossrefPubMedGoogle Scholar
  • 32 McDermott MM, Greenland P, Liu K. , et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002; 136 (12) 873-883
    CrossrefPubMedGoogle Scholar
  • 33 McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. Circulation 2000; 101 (09) 1007-1012
    CrossrefPubMedGoogle Scholar
  • 34 McDermott MM, Greenland P, Liu K. , et al. Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc 2003; 51 (02) 222-228
    CrossrefPubMedGoogle Scholar
  • 35 Mazhari R, Hsia J. Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?. Vasc Health Risk Manag 2005; 1 (02) 111-117
    CrossrefPubMedGoogle Scholar
  • 36 Hobbs SD, Bradbury AW. Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach. Eur J Vasc Endovasc Surg 2003; 26 (04) 341-347
    CrossrefPubMedGoogle Scholar
  • 37 Robless P, Mikhailidis DP, Stansby GP. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev 2008; (01) CD003748
    PubMedGoogle Scholar
  • 38 Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med 2010; 15 (03) 181-188
    CrossrefPubMedGoogle Scholar
  • 39 Lane R, Ellis B, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev 2014; (07) CD000990
    PubMedGoogle Scholar
  • 40 Conte MS, Pomposelli FB, Clair DG. , et al; Society for Vascular Surgery Lower Extremity Guidelines Writing Group; Society for Vascular Surgery. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 2015; 61 (3, Suppl): 2S-41S
    CrossrefPubMedGoogle Scholar
  • 41 Lundgren F, Dahllöf AG, Lundholm K, Scherstén T, Volkmann R. Intermittent claudication--surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency. Ann Surg 1989; 209 (03) 346-355
    CrossrefPubMedGoogle Scholar
  • 42 Trialists'Collaboration A. ; Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324 (7329): 71-86
    CrossrefPubMedGoogle Scholar
  • 43 Belch J, MacCuish A, Campbell I. , et al; Prevention of Progression of Arterial Disease and Diabetes Study Group; Diabetes Registry Group; Royal College of Physicians Edinburgh. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008; 337: a1840
    CrossrefPubMedGoogle Scholar
  • 44 Feinglass J, McDermott MM, Foroohar M, Pearce WH. Gender differences in interventional management of peripheral vascular disease: evidence from a blood flow laboratory population. Ann Vasc Surg 1994; 8 (04) 343-349
    CrossrefPubMedGoogle Scholar
  • 45 Egorova N, Vouyouka AG, Quin J. , et al. Analysis of gender-related differences in lower extremity peripheral arterial disease. J Vasc Surg 2010; 51 (02) 372-8.e1 , discussion 378–379
    CrossrefPubMedGoogle Scholar
  • 46 Lancaster RT, Conrad MF, Patel VI, Cambria RP, LaMuraglia GM. Predictors of early graft failure after infrainguinal bypass surgery: a risk-adjusted analysis from the NSQIP. Eur J Vasc Endovasc Surg 2012; 43 (05) 549-555
    CrossrefPubMedGoogle Scholar
  • 47 Nguyen LL, Brahmanandam S, Bandyk DF. , et al. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg 2007; 46 (06) 1191-1197
    CrossrefPubMedGoogle Scholar
  • 48 Jain AK, Velazquez-Ramirez G, Goodney PP, Edwards MS, Corriere MA. Gender-based analysis of perioperative outcomes associated with lower extremity bypass. Am Surg 2011; 77 (07) 844-849
    PubMedGoogle Scholar
  • 49 Vouyouka AG, Egorova NN, Salloum A. , et al. Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial disease. J Vasc Surg 2010; 52 (05) 1196-1202
    CrossrefPubMedGoogle Scholar
  • 50 Pulli R, Dorigo W, Pratesi G, Fargion A, Angiletta D, Pratesi C. Gender-related outcomes in the endovascular treatment of infrainguinal arterial obstructive disease. J Vasc Surg 2012; 55 (01) 105-112
    CrossrefPubMedGoogle Scholar
  • 51 Jackson EA, Munir K, Schreiber T. , et al. Impact of sex on morbidity and mortality rates after lower extremity interventions for peripheral arterial disease: observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Cardiol 2014; 63 (23) 2525-2530
    CrossrefPubMedGoogle Scholar
  • 52 Gallagher KA, Meltzer AJ, Ravin RA. , et al. Gender differences in outcomes of endovascular treatment of infrainguinal peripheral artery disease. Vasc Endovascular Surg 2011; 45 (08) 703-711
    CrossrefPubMedGoogle Scholar
  • 53 Norgren L, Hiatt WR, Dormandy JA. , et al; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (01) (Suppl. 01) S1-S75
    CrossrefPubMedGoogle Scholar
  • 54 Goode SD, Cleveland TJ, Gaines PA. ; STAG Trial Collaborators. Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial). Br J Surg 2013; 100 (09) 1148-1153
    CrossrefPubMedGoogle Scholar
  • 55 Timaran CH, Stevens SL, Freeman MB, Goldman MH. External iliac and common iliac artery angioplasty and stenting in men and women. J Vasc Surg 2001; 34 (03) 440-446
    CrossrefPubMedGoogle Scholar
  • 56 Bechter-Hugl B, Falkensammer J, Gorny O, Greiner A, Chemelli A, Fraedrich G. The influence of gender on patency rates after iliac artery stenting. J Vasc Surg 2014; 59 (06) 1588-1596
    CrossrefPubMedGoogle Scholar
  • 57 Krankenberg H, Schlüter M, Steinkamp HJ. , et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116 (03) 285-292
    CrossrefPubMedGoogle Scholar
  • 58 Tadros RO, Vouyouka AG, Ting W. , et al. A review of superficial femoral artery angioplasty and stenting. J Vasc Med Surg 2015; 3: 183
    PubMedGoogle Scholar
  • 59 Romiti M, Albers M, Brochado-Neto FC, Durazzo AES, Pereira CAB, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47 (05) 975-981
    CrossrefPubMedGoogle Scholar
  • 60 Schmidt A, Ulrich M, Winkler B. , et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 2010; 76 (07) 1047-1054
    CrossrefPubMedGoogle Scholar
  • 61 Scheinert D, Katsanos K, Zeller T. , et al; ACHILLES Investigators. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol 2012; 60 (22) 2290-2295
    CrossrefPubMedGoogle Scholar